Advertisement
Screener

EQUIFAX INC (EFX) SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense

2.1 / 5 stars · 46/110 Roast Me

EQUIFAX INC SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense

EQUIFAX INC (EFX) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense of $47.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.

Financial Statements › Notes › Valuation and Qualifying Accounts

us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense · last filed 2026-02-19

  • EQUIFAX INC sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2025 was $47.40M, a 33.90% increase from fiscal 2024.
  • EQUIFAX INC sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2024 was $35.40M.
  • EQUIFAX INC sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2023 was -$15.50M.
  • EQUIFAX INC sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2022 was -$6.90M.
Period endSEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 12 month
2025-12-31$47.40M
10-K · filed 2026-02-19
2024-12-31$35.40M
10-K · filed 2026-02-19
2023-12-31-$15.50M
10-K · filed 2026-02-19
2022-12-31-$6.90M
10-K · filed 2025-02-20
2021-12-31-$12.40M
10-K · filed 2024-02-22
2020-12-31-$28.10M
10-K · filed 2023-02-23
2019-12-31-$56.50M
10-K · filed 2022-02-24
2018-12-31-$158.40M
10-K · filed 2021-02-25
2017-12-31-$1.10M
10-K · filed 2020-02-20
2016-12-31-$231.50M
10-K · filed 2019-02-21
2015-12-31$2.80M
10-K · filed 2018-03-01
2014-12-31-$1.10M
10-K · filed 2017-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
TransUnion (TRU)United States$13.027B18.94
MOODYS CORP /DE/ (MCO)United States$80.966B28.07
S&P Global Inc. (SPGI)United States$119.368B26.35